Claims
- 1. A peptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NO: 1 through SEQ ID No. 25.
- 2. The peptide according to claim 1, bound to an adjuvant through chemical interaction.
- 3. The peptide according to claim 1, having the sequence of SEQ ID NO. 1.
- 4. The peptide according to claim 2, having the sequence of SEQ ID NO: 1.
- 5. The peptide according to claim 1, which is genetically encoded by a nucleotide sequence selected from the group consisting of SEQ ID NO: 26 through SEQ ID NO: 50, respectively, or by a nucleotide sequence equivalent thereto due to the degeneracy of the genetic code.
- 6. The peptide according to claim 2, wherein said adjuvant is selected from the group consisting of an antibody, an antibody fragment, a virus, a part of a virus, a phage and glutathione S-transferase.
- 7. The peptide according to claim 6, having the sequence of SEQ ID No. 1.
- 8. The peptide according to claim 6, wherein the adjuvant is an antibody.
- 9. The peptide according to claim 6, wherein the adjuvant is an antibody fragment.
- 10. The peptide according to claim 6, wherein the adjuvant is a virus.
- 11. The peptide according to claim 6, wherein the adjuvant is part of a virus.
- 12. The peptide according to claim 6, wherein the adjuvant is a phage.
- 13. The peptide according to claim 6, wherein the adjuvant is glutathione S-transferase.
Priority Claims (1)
Number |
Date |
Country |
Kind |
987/92 |
May 1992 |
ATX |
|
Parent Case Info
This application is a continuation of application Ser. No. 07/932,787 filed on Aug. 29, 1992, now abandoned.
Foreign Referenced Citations (1)
Number |
Date |
Country |
0330359 |
Aug 1989 |
EPX |
Continuations (1)
|
Number |
Date |
Country |
Parent |
932787 |
Aug 1992 |
|